TA BlueTech Index

MassChallenge and MITRE Announce the MITRE Social Innovation Mentorship Program

Retrieved on: 
Friday, November 4, 2022

For specifics on these challenge areas, and information about MITRE experts serving as mentors, please consult the program landing page.

Key Points: 
  • For specifics on these challenge areas, and information about MITRE experts serving as mentors, please consult the program landing page.
  • We are proud to deepen our relationship with MassChallenge by partnering with our Corporate Social Innovation function to strengthen MITRE's commitment in co-creating with underserved populations.
  • Through this program, we aim to elevate the next generation of innovators through mentorship and access to resources by lowering barriers of entry for underrepresented entrepreneurs, said Stephanie Turner, vice president of Diversity, Inclusion, & Social Innovation, MITRE.
  • Over the course of this eight-year relationship, MITRE researchers, engineers, and scientists have engaged with countless startups participating in MassChallenge programs.

Following over 10x Performance of its First Fund, at.inc/ -- The Seed Fund That Partners With Founders "At Incorporation" (formerly known as Tank Hill Ventures) -- Raises Oversubscribed $35M Fund II

Retrieved on: 
Thursday, March 24, 2022

SAN FRANCISCO, March 24, 2022 /PRNewswire/ -- at.inc/ today announced it has closed on an oversubscribed $35 million Fund II to double down on its fund strategy of investing globally in founders "at incorporation" and backing them all the way with flexible capital from its influential limited partner network. In this new fund Nadav Eylath is partnering with 20+ year high school friend Roni Bonjack to combine his proven track record leading seed rounds with Roni's operational expertise in building and scaling startup programs for Google and Facebook globally. Bonjack was the person who scaled Google Launchpad from a pilot to a global program. She also led Developer and Startup Programs for Facebook, where she's built accelerators in five countries throughout EMEA. The fund is backed by LPs that include founders of the top performing VCs, private equity, hedge, and secondary funds in the US, as well as corporate executives, and founders of unicorns that at.inc/ has backed since inception.

Key Points: 
  • She also led Developer and Startup Programs for Facebook, where she's built accelerators in five countries throughout EMEA.
  • "We invest based on our own conviction when we connect to the founder's vision and mission and then back founders continuously, throughout the best and toughest times alike," said Eylath.
  • "We've already made remarkable investments out of this new fund in frontier startups that are addressing big problems in sustainability, bluetech, spacetech, urbantech and XR."
  • Its first fund (2015 vintage) performance is currently more than 10x, with four exits (one IPO), and positions in six unicorns.

Gilat Awarded Multi-Million Dollar Contract to Provide Satellite Communication Equipment for Defense Forces in Asia

Retrieved on: 
Wednesday, July 7, 2021

PETAH TIKVA, Israel, July 07, 2021 (GLOBE NEWSWIRE) -- Gilat Satellite Networks Ltd. (Nasdaq: GILT, TASE: GILT), a worldwide leader in satellite networking technology, solutions and services, announced today an award of a multi-million-dollar contract to provide satellite communication (SATCOM) equipment to a large system integrator for its customer in Asia.

Key Points: 
  • PETAH TIKVA, Israel, July 07, 2021 (GLOBE NEWSWIRE) -- Gilat Satellite Networks Ltd. (Nasdaq: GILT, TASE: GILT), a worldwide leader in satellite networking technology, solutions and services, announced today an award of a multi-million-dollar contract to provide satellite communication (SATCOM) equipment to a large system integrator for its customer in Asia.
  • "Gilat was chosen to answer the defense needs due to Gilat's superior technology, highly secure solution, proven global track record and commitment to the local market," said Vinod Kaul, General Manager South Asia at Gilat.
  • "This contract is an additional significant step in implementing Gilat's strategy in the global Defense market."
  • Gilat Satellite Networks Ltd. (NASDAQ: GILT, TASE: GILT) is a leading global provider of satellite-based broadband communications.

Tier-1 Telco in Latin America Awards Gilat Over $3M to Provide Broadband Connectivity in Support of Bridging the Digital Divide

Retrieved on: 
Monday, April 26, 2021

b'PETAH TIKVA, Israel, April 26, 2021 (GLOBE NEWSWIRE) -- Gilat Satellite Networks Ltd. (NASDAQ, TASE: GILT), a worldwide leader in satellite networking technology, solutions and services, announced today that a Tier-1 Telco in Latin America awarded Gilat over $3M to provide broadband connectivity over satellite to support bridging the digital divide.

Key Points: 
  • b'PETAH TIKVA, Israel, April 26, 2021 (GLOBE NEWSWIRE) -- Gilat Satellite Networks Ltd. (NASDAQ, TASE: GILT), a worldwide leader in satellite networking technology, solutions and services, announced today that a Tier-1 Telco in Latin America awarded Gilat over $3M to provide broadband connectivity over satellite to support bridging the digital divide.
  • "We are excited with the opportunity to support our partners with our leading technology and to share a common vision of bridging the digital divide, by delivering broadband connectivity worldwide to those who need it most.
  • "\nGilat Satellite Networks Ltd. (NASDAQ: GILT, TASE: GILT) is a leading global provider of satellite-based broadband communications.
  • With 30 years of experience, we design and manufacture cutting-edge ground segment equipment, and provide comprehensive solutions and end-to-end services, powered by our innovative technology.

Nasdaq Resumes Trading in Generations Bancorp NY, Inc.

Retrieved on: 
Friday, January 15, 2021

NEW YORK, Jan. 15, 2021 (GLOBE NEWSWIRE) -- The Nasdaq Stock Market (Nasdaq: NDAQ) announced that trading resumed today in Generations Bancorp NY, Inc. (Nasdaq: GBNY) at 8:15 a.m. Eastern Time on January 15, 2021.

Key Points: 
  • NEW YORK, Jan. 15, 2021 (GLOBE NEWSWIRE) -- The Nasdaq Stock Market (Nasdaq: NDAQ) announced that trading resumed today in Generations Bancorp NY, Inc. (Nasdaq: GBNY) at 8:15 a.m. Eastern Time on January 15, 2021.
  • Trading in the companys stock was halted on January 14, 2021 at 17:10:16 Eastern Time.
  • For news and additional information about the company, please contact the company directly or check under the companys symbol using InfoQuotesSM on the Nasdaq Web site.
  • For more information about The Nasdaq Stock Market, visit the Nasdaq Web site at http://www.nasdaq.com .

The Tel-Aviv Stock Exchange Launches the TA-Cannabis Index

Retrieved on: 
Monday, December 28, 2020

TEL AVIV, Israel, Dec. 28, 2020 /PRNewswire/ -- The Tel-Aviv Stock Exchange (TASE: TASE) announced today the launch of a new index that will comprise shares of companies included the Cannabis Subsector, under the Biomed Sector.

Key Points: 
  • TEL AVIV, Israel, Dec. 28, 2020 /PRNewswire/ -- The Tel-Aviv Stock Exchange (TASE: TASE) announced today the launch of a new index that will comprise shares of companies included the Cannabis Subsector, under the Biomed Sector.
  • The Israeli medical cannabis industry has evolved in recent years and, while not yet mature, has gained rapport in the capital market.
  • The majority of shares in the Cannabis Subsector are included in the TA-Growth Index and only one is included in the TA-SME60 Index.
  • The TA-Cannabis Index will include the shares of companies that TASE has classified to the Cannabis Subsector, with a weight cap of 15% for shares included in the index.

Kamada Added to the NASDAQ Biotechnology Index

Retrieved on: 
Monday, December 21, 2020

REHOVOT, Israel, Dec. 21, 2020 (GLOBE NEWSWIRE) -- Kamada Ltd. (NASDAQ: KMDA; TASE: KMDA.TA), a plasma-derived biopharmaceutical company, today announced that it has been selected for addition to the NASDAQ Biotechnology Index(Nasdaq: NBI).

Key Points: 
  • REHOVOT, Israel, Dec. 21, 2020 (GLOBE NEWSWIRE) -- Kamada Ltd. (NASDAQ: KMDA; TASE: KMDA.TA), a plasma-derived biopharmaceutical company, today announced that it has been selected for addition to the NASDAQ Biotechnology Index(Nasdaq: NBI).
  • The annual re-ranking of the NASDAQ Biotechnology Index will become effective prior to market open on Monday, December 21, 2020.
  • The NASDAQ Biotechnology Index (NBI) is a modified market-cap weighted index designed to track the performance of a set of securities listed on the NASDAQ Stock Market (NASDAQ) that are classified as either biotechnology or pharmaceutical according to the Industry Classification Benchmark.
  • Additionally, the NBI forms the basis for a number of Exchange Traded Funds (ETFs), including the iShares NASDAQ Biotechnology ETF (Nasdaq: IBB).

Repare Therapeutics Added to the NASDAQ Biotechnology Index

Retrieved on: 
Thursday, December 17, 2020

Repare Therapeutics, Inc. (Repare or the Company) (Nasdaq: RPTX), a leading clinical-stage precision oncology company enabled by its proprietary synthetic lethality approach to the discovery and development of novel therapeutics, today announced that it has been selected for addition to the NASDAQ Biotechnology Index (NASDAQ: ^NBI).

Key Points: 
  • Repare Therapeutics, Inc. (Repare or the Company) (Nasdaq: RPTX), a leading clinical-stage precision oncology company enabled by its proprietary synthetic lethality approach to the discovery and development of novel therapeutics, today announced that it has been selected for addition to the NASDAQ Biotechnology Index (NASDAQ: ^NBI).
  • The NASDAQ Biotechnology Index is designed to track the performance of a set of securities listed on The NASDAQ Stock Market (NASDAQ) that are classified as either biotechnology or pharmaceutical according to the Industry Classification Benchmark.
  • The NASDAQ Biotechnology Index is calculated under a modified capitalization-weighted methodology and ranked on an annual basis.
  • All securities in the NASDAQ Biotechnology Index are listed on the NASDAQ Global Market or the NASDAQ Global Select Market and meet minimum market value and share volume requirements, among other criteria.

Ovid Therapeutics Announces Addition to the Nasdaq Biotechnology Index

Retrieved on: 
Wednesday, December 16, 2020

NEW YORK, Dec. 16, 2020 (GLOBE NEWSWIRE) -- Ovid Therapeutics Inc.(NASDAQ: OVID), a biopharmaceutical company committed to developing medicines that transform the lives of people with rare neurological diseases, today announced that it has been added to the Nasdaq Biotechnology Index (Nasdaq: NBI).

Key Points: 
  • NEW YORK, Dec. 16, 2020 (GLOBE NEWSWIRE) -- Ovid Therapeutics Inc.(NASDAQ: OVID), a biopharmaceutical company committed to developing medicines that transform the lives of people with rare neurological diseases, today announced that it has been added to the Nasdaq Biotechnology Index (Nasdaq: NBI).
  • The NASDAQ Biotechnology Index is designed to track the performance of a set of securities listed on the NASDAQ Stock Market(NASDAQ) that are classified as either biotechnology or pharmaceutical according to the Industry Classification Benchmark (ICB).
  • The NASDAQ Biotechnology Index is re-ranked annually and all securities in the index are listed on the NASDAQ Global Market or the NASDAQ Global Select Market, and meet minimum market value and share volume requirements among other criteria.
  • The NASDAQ Biotechnology Index is the basis for the iShares NASDAQ Biotechnology IndexSMFund.

MediciNova Added to the NASDAQ Biotechnology Index

Retrieved on: 
Tuesday, December 15, 2020

LA JOLLA, Calif., Dec. 15, 2020 (GLOBE NEWSWIRE) -- MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market (NASDAQ:MNOV) and the JASDAQ Market of the Tokyo Stock Exchange (Code Number: 4875), today announced that MediciNova will be added to the NASDAQ Biotechnology Index (NASDAQ: NBI) effective prior to the market open on Monday, December 21, 2020.

Key Points: 
  • LA JOLLA, Calif., Dec. 15, 2020 (GLOBE NEWSWIRE) -- MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market (NASDAQ:MNOV) and the JASDAQ Market of the Tokyo Stock Exchange (Code Number: 4875), today announced that MediciNova will be added to the NASDAQ Biotechnology Index (NASDAQ: NBI) effective prior to the market open on Monday, December 21, 2020.
  • The NASDAQ Biotechnology Index (NBI) is designed to track the performance of a set of securities listed on the NASDAQ Stock Market (NASDAQ) that are classified as either biotechnology or pharmaceutical according to the Industry Classification Benchmark.
  • The NASDAQ Biotechnology Index is the benchmark index for the iShares Nasdaq Biotechnology ETF (exchange-traded fund) (NASDAQ: IBB), which has net assets of $10.2 billion, as well as for other biotechnology-focused ETFs and mutual funds.
  • Yuichi Iwaki, MD, PhD, President and Chief Executive Officer of MediciNova, Inc., commented, We are excited that MediciNova has been added to the NASDAQ Biotechnology Index and we believe that our inclusion in this index will raise our profile in the investment community.